"Recurrence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The return of a sign, symptom, or disease after a remission.
| Descriptor ID |
D012008
|
| MeSH Number(s) |
C23.550.291.937
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Recurrence".
Below are MeSH descriptors whose meaning is more specific than "Recurrence".
This graph shows the total number of publications written about "Recurrence" by people in this website by year, and whether "Recurrence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 13 | 13 |
| 1997 | 0 | 20 | 20 |
| 1998 | 0 | 20 | 20 |
| 1999 | 0 | 23 | 23 |
| 2000 | 0 | 18 | 18 |
| 2001 | 0 | 22 | 22 |
| 2002 | 0 | 17 | 17 |
| 2003 | 0 | 16 | 16 |
| 2004 | 0 | 16 | 16 |
| 2005 | 0 | 24 | 24 |
| 2006 | 0 | 28 | 28 |
| 2007 | 0 | 19 | 19 |
| 2008 | 0 | 31 | 31 |
| 2009 | 0 | 22 | 22 |
| 2010 | 0 | 38 | 38 |
| 2011 | 0 | 35 | 35 |
| 2012 | 0 | 36 | 36 |
| 2013 | 0 | 31 | 31 |
| 2014 | 0 | 33 | 33 |
| 2015 | 0 | 30 | 30 |
| 2016 | 1 | 35 | 36 |
| 2017 | 0 | 26 | 26 |
| 2018 | 1 | 33 | 34 |
| 2019 | 0 | 40 | 40 |
| 2020 | 0 | 38 | 38 |
| 2021 | 0 | 30 | 30 |
| 2022 | 0 | 18 | 18 |
| 2023 | 0 | 22 | 22 |
| 2024 | 6 | 22 | 28 |
| 2025 | 0 | 16 | 16 |
To return to the timeline,
click here.
Below are the most recent publications written about "Recurrence" by people in Profiles.
-
Management of Perianal Abscesses in Infants: A Systematic Review From the APSA Outcomes and Evidence-Based Practice Committee. J Pediatr Surg. 2025 Dec; 60(12):162691.
-
Risk of Stroke Recurrence Following Isolated Retinal Artery Occlusion Versus Minor Stroke or Transient Ischemic Attack. Stroke. 2025 Dec; 56(12):3394-3403.
-
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study. Blood. 2025 Aug 28; 146(9):1065-1077.
-
Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement. Blood Adv. 2025 Aug 26; 9(16):4081-4089.
-
Outcomes of Patients With Embolic Stroke of Undetermined Source Treated With Antiplatelet Agents or Anticoagulation: A Multicenter Cohort Study. Neurology. 2025 Aug 12; 105(3):e213876.
-
Nicotine dependence, perceived barriers, and affective vulnerability among individuals engaging in dual use who report relapse: Implications for targeted treatment. Addict Behav. 2025 Nov; 170:108422.
-
Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study. Haematologica. 2026 Jan 01; 111(1):177-183.
-
Statin initiation and early stroke recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial (POINT) trial population. J Stroke Cerebrovasc Dis. 2025 Jul; 34(7):108349.
-
Stroke risk prediction in symptomatic anterior circulation ICAD: Analysis of regional QMRA flow from the MYRIAD study. J Stroke Cerebrovasc Dis. 2025 Jun; 34(6):108322.
-
Exploring Drivers of Binge Eating in Individuals With Food Insecurity and Recurrent Binge Eating: A Qualitative Analysis. Int J Eat Disord. 2025 Jul; 58(7):1244-1255.